Ann: Update - ASX Enquiry, page-179

Oh, If you happen to have spare cash, then if CSL drops below $178 again (as it has only twice in the last 3 months), then this would be a good buy and hold stock. If I had done this 12 months ago, then even though the stock is expensive I would have doubled my money. Worth riding the dips with a stock like this, it will go up and if patient will definitely be a $300 plus and maybe an over $700 a share stock. I used to work with their ip team, they know what they are doing. One of the few biotechs I trust to hold value